PLIANT THERAPEUTICS, INC.
Developing novel integrin-based therapies for fibrosis and related diseases.
PLRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7291391057
- LEI:
- Country:
- United States of America
- Address:
- 331 OYSTER POINT BOULEVARD, 94080 SOUTH SAN FRANCISCO
- Website:
- https://pliantrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. The company leverages its proprietary discovery platform to create tissue-specific, integrin-based therapies. Its scientific approach centers on understanding and modulating the molecular drivers of fibrotic diseases, particularly TGF-β1 signaling, to develop potentially safer and more effective treatments. Pliant's development pipeline includes programs targeting a range of conditions, such as idiopathic pulmonary fibrosis (IPF), primary sclerosing cholangitis (PSC), and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PLIANT THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PLIANT THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PLIANT THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
